Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals

Diabetes Care ◽  
1999 ◽  
Vol 22 (12) ◽  
pp. 1988-1992 ◽  
Author(s):  
B. Lindahl ◽  
L. Weinehall ◽  
K. Asplund ◽  
G. Hallmans
Keyword(s):  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Population Based ◽  
Population Based Study

Population-Based Study of Impaired Glucose Tolerance and Type II Diabetes in Wadena, Minnesota

Diabetes ◽  
1990 ◽  
Vol 39 (9) ◽  
pp. 1131-1137 ◽  
Author(s):  
L. R. French ◽  
J. R. Boen ◽  
A. M. Martinez ◽  
S. A. Bushhouse ◽  
J. M. Sprafka ◽  
...  
Keyword(s):  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Type Ii Diabetes ◽  
Population Based ◽  
Type Ii ◽  
Population Based Study

A Population-Based Study of the Prevalence of Diabetes and Impaired Glucose Tolerance in Adults in Northern Sudan

Diabetes Care ◽  
1996 ◽  
Vol 19 (10) ◽  
pp. 1126-1128 ◽  
Author(s):  
M. N. Elbagir ◽  
M. A. Eltom ◽  
E. M. Elmahadi ◽  
I. M. Kadam ◽  
C. Berne
Keyword(s):  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Population Based ◽  
Population Based Study

scholarly journals Perceived Symptoms in People Living with Impaired Glucose Tolerance

2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Susanne Andersson ◽  
Inger Ekman ◽  
Ulf Lindblad ◽  
Febe Friberg
Keyword(s):  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Health Professionals ◽  
Population Based ◽  
The Body ◽  
Cross Sectional ◽  
Population Based Study ◽  
Bodily Sensations ◽  
Two Phases ◽  
Latent Content

The aim of the study was to identify symptoms in people with impaired glucose tolerance (IGT) and describe their experiences of living with the symptoms which they related to their condition. Twenty-one participants, from a cross-sectional population-based study, diagnosed as having IGT, were invited for an interview. The interviews were analyzed in two phases by means of a manifest and latent content analysis. The narratives included seven categories of symptoms (and more than 25 different symptoms) presented by the respondents. This study shows that symptoms such as the patient's own interpretation of different perceptions in the body must be considered, as well as signs and/or objective observations. Symptoms ought to be seen as complementary components in the health encounter and health conversation. The results of this study indicate that health professionals should increase their awareness of the balance between the implicit and the explicit bodily sensations that individuals communicate. Further studies are needed.

Population-based study of impaired glucose tolerance and type II diabetes in Wadena, Minnesota

Diabetes ◽  
1990 ◽  
Vol 39 (9) ◽  
pp. 1131-1137 ◽  
Author(s):  
L. R. French ◽  
J. R. Boen ◽  
A. M. Martinez ◽  
S. A. Bushhouse ◽  
J. M. Sprafka ◽  
...  
Keyword(s):  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Type Ii Diabetes ◽  
Population Based ◽  
Type Ii ◽  
Population Based Study

scholarly journals Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)

2006 ◽  
Vol 154 (2) ◽  
pp. 311-317 ◽  
Author(s):  
Christian Herder ◽  
Sylvia Müller-Scholze ◽  
Philipp Rating ◽  
Wolfgang Koenig ◽  
Barbara Thorand ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Health Research ◽  
Population Based ◽  
Monocyte Chemoattractant Protein 1 ◽  
Monocyte Chemoattractant ◽  
Monocyte Chemoattractant Protein ◽  
Design And Methods

Objective: Data on the relevance of monocyte chemoattractant protein (MCP)-1 in the pathophysiology of type 2 diabetes (T2D) and obesity are inconsistent. Since MCP-1 is produced by adipocytes and has been postulated to be involved in macrophage infiltration into adipose tissue, we wanted to test whether serum MCP-1 levels were correlated with T2D or obesity. Design and methods: Out of 1653 individuals aged 55 to 74 years participating in the population-based KORA Survey S4 (KORA/Cooperative Health Research in the Region of Augsburg) in Southern Germany, 236 patients with T2D, 242 subjects with impaired glucose tolerance and 244 normoglycaemic controls matched for age and sex were analysed for circulating MCP-1 concentrations. Results: MCP-1 serum concentrations were not associated with impaired glucose tolerance, type 2 diabetes or several parameters of obesity. Moreover, systemic MCP-1 levels were not significantly correlated with all but one (fasting triglycerides) of the biochemical markers tested. Conclusions: Our data indicate that MCP-1 levels are not associated with T2D and that the contribution of fat mass to systemic MCP-1 protein might be low, suggesting that the possible local pathogenic role of MCP-1 may not be reflected by increased systemic levels of MCP-1.

Sign in / Sign up

Export Citation Format

Share Document